Thursday, 23 March 2017

Insights into Pathophysiology of Carotid Baroreceptor Stimulation as a Method for Treatment of Resistant Hypertension

Arterial hypertension (AH) is a major health problem worldwide, with a high prevalence in general population. It is also an important risk factor for cardiovascular (CVD) and renal (RD) diseases. 

Resistant Hypertension
According to WHO data, about 30-50% of the adult population suffer from AH. The prevalence of AH in 2025 is expected to rise by60% (29.2%-1.56 billion people) from the current 26.4% (972 million people inyear 2000). Hypertension remains a major risk factor for early renal failure, stroke, heart failure and heart attack. The risk of end-stage chronic kidney disease and myocardial infarction is four times higher in persons with systolic blood pressure above 160 mmHg than in those with normal blood pressure, and the risk of developing heart failure is two times higher in persons after the age of forty.  Read more>>>>>>>>>>>>>


No comments:

Post a Comment